Approval · Notice of Compliance 26294 · 2021
LUVOX: Notice of Compliance 26294
Issued July 21, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26294
- Date
- July 21, 2021
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph including to upgrade the product monograph to the 2020 format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUVOX | Not yet assigned | — |
Medicinal ingredients
- FLUVOXAMINE MALEATE 50 MG per TAB
- FLUVOXAMINE MALEATE 100 MG per TAB